Galinsoga parviflora (Cav.): A comprehensive review on ethnomedicinal, phytochemical and pharmacological studies.

Heliyon

Department of Chemistry, College of Natural and Mathematical Sciences, The University of Dodoma, P.O. Box 338, Dodoma, Tanzania.

Published: February 2023

(Cav.) is a member of the Asteraceae family traditionally used for treatment of various ailments such as malaria, flu, cold, colorectal cancer, liver problems and inflammation. The medicinal properties of are due to the presence of various secondary metabolites including flavonoids, saponins, terpenoids and tannins. The literature survey revealed that possesses several pharmacological properties such as antibacterial, antifungal, antioxidant and antidiabetic. This review systematically discusses the potential of for managing medical conditions. The information is collected from various online databases such as Google Scholar, ScienceDirect, Springer, Web of Science, Plant of the World Online and PubMed. Among other information provided in this review, ethnomedicinal uses, phytochemistry and pharmacological activities are discussed extensively. Additonally, the potential benefits, challenges and future opportunities are presented.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946856PMC
http://dx.doi.org/10.1016/j.heliyon.2023.e13517DOI Listing

Publication Analysis

Top Keywords

review ethnomedicinal
8
galinsoga parviflora
4
parviflora cav
4
cav comprehensive
4
comprehensive review
4
ethnomedicinal phytochemical
4
phytochemical pharmacological
4
pharmacological studies
4
studies cav
4
cav member
4

Similar Publications

Background: Prostate cancer treatment involves hormonal therapies that may carry cardiovascular risks, particularly for long-term use. Gonadotropin-releasing hormone (GnRH) antagonists, such as degarelix, may offer advantages over agonists, but comprehensive comparative cardiovascular outcomes are not well established. This study aimed to systematically review and analyze the cardiovascular safety profiles of degarelix compared to those of traditional GnRH agonists, providing critical insights for optimizing treatment strategies.

View Article and Find Full Text PDF

Can microbiota gut-brain axis reverse neurodegenerative disorders in human?

Ageing Res Rev

January 2025

Medical Science and Technology Innovation Center, Shandong Key Laboratory of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong 250117, P R China; School of Medicine and Allied Health Sciences, University of The Gambia; Department of Medical Microbiology, Central South University Changsha, Hunan Provinces, China. Electronic address:

The trillions of microbial populations residing in the gut have recently shown that they can be used as a remedy for various diseases. The gut microbiota-brain-axis interface is one unique pathway that the microbiota demonstrates its medicinal value. This medicinal value is further seen when there is a decline in gut microbial diversity (dysbiosis).

View Article and Find Full Text PDF

Dissection of type 2 diabetes: a genetic perspective.

Lancet Diabetes Endocrinol

January 2025

Université de Lille, Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, Lille, France; Department of Metabolism, Imperial College London, London, UK. Electronic address:

Diabetes is a leading cause of global mortality and disability, and its economic burden is substantial. This Review focuses on type 2 diabetes, which makes up 90-95% of all diabetes cases. Type 2 diabetes involves a progressive loss of insulin secretion often alongside insulin resistance and metabolic syndrome.

View Article and Find Full Text PDF

Retinal artery occlusion (RAO) is a critical ophthalmic emergency with a high risk of significant visual impairment. While traditional treatment aims to promptly restore blood flow to the retina, recent research has investigated the potential benefits of anticoagulation therapy for managing this condition. This paper reviews current literature and clinical trials investigating the efficacy and safety of anticoagulant and antiplatelet therapies, such as systemic heparinization and direct oral anticoagulants and aspirin, in treating RAO.

View Article and Find Full Text PDF

Medical Problems of Chronic Hypoxia in Highlanders Living on the Tibetan Plateau.

High Alt Med Biol

January 2025

The Research Center for High Altitude Medicine, Qinghai University, Xining, China.

Ri-Li Ge. Medical problems of chronic hypoxia in highlanders living on the tibetan plateau. 00:00-00, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!